JNJ
Johnson & Johnson
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
+10/100
Last price
255.00
▲ 2.07 (0.82%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
253.86
Prev close
252.93
Day high
255.48
Day low
251.17
Volume
5.66M
Market cap
$613.99B
P/E (TTM)
29.52
52W range
182.94 – 281.07
Day trading desk
Gap from prior close
+0.37%
Prior close 252.93
VWAP
253.56
+0.57% from price
Relative volume
1.84×
Unusually busy
Session range
1.72%
251.17 – 255.48
Position in range
89%
Near session high
ATR (14D)
4.81
1.89% of price
Prior day high
256.24
PDH
Prior day low
252.51
PDL
Bid / ask spread
—
Quote not published
Session volume
13.08M
Avg 7.09M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.78%
-6.7%
1M
-7.43%
-8.6%
3M
-3.27%
-7.8%
6M
+6.87%
-11.3%
YTD
+23.11%
+8.9%
1Y
+35.06%
+18.6%
3Y
+63.58%
-18.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on JNJ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-29.80K
Net selling
Buy transactions
7
239.54K shares
Sell transactions
7
269.34K shares
Net transactions
+14
Buys less sells
Sell : buy shares
1.1 : 1
Mixed
Insider-held shares
1.28M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 2, 26 | SCHMID TIMOTHY Officer |
SELL | 33.60K | $9.23M | Direct |
| Sep 2, 26 | SCHMID TIMOTHY Officer |
CONVERSION | 33.60K | $4.87M | Direct |
| Aug 17, 26 | TAUBERT JENNIFER L Officer |
SELL | 15.00K | $3.95M | Direct |
| Aug 17, 26 | TAUBERT JENNIFER L Officer |
CONVERSION | 15.00K | $1.74M | Direct |
| Aug 13, 26 | DUATO JOAQUIN BOIX Chief Executive Officer |
SELL | 123.29K | $32.20M | Direct |
| Aug 13, 26 | DUATO JOAQUIN BOIX Chief Executive Officer |
CONVERSION | 123.29K | $14.26M | Direct |
| Aug 6, 26 | FORMINARD ELIZABETH Officer |
SELL | 15.92K | $4.09M | Direct |
| Aug 6, 26 | FORMINARD ELIZABETH Officer |
CONVERSION | 9.34K | $1.23M | Direct |
| Aug 5, 26 | DUATO JOAQUIN BOIX Chief Executive Officer |
SELL | 48.48K | $12.52M | Direct |
| Jul 20, 26 | BROADHURST VANESSA Officer |
SELL | 23.05K | $5.79M | Direct |
| Jul 20, 26 | BROADHURST VANESSA Officer |
CONVERSION | 23.05K | $3.01M | Direct |
| Jun 11, 26 | WENGEL KATHRYN E Chief Technology Officer |
SELL | 10.00K | $2.41M | Direct |
| Jun 11, 26 | WENGEL KATHRYN E Chief Technology Officer |
CONVERSION | 10.00K | $1.16M | Direct |
| May 1, 26 | REED JOHN C Officer |
— | 25.25K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BROADHURST VANESSA |
Officer | 23.00K | Sale |
DECKER ROBERT J |
Officer | 24.46K | Sale |
DUATO JOAQUIN BOIX |
Chief Executive Officer | 307.84K | Sale |
MULHOLLAND KRISTEN |
Officer | 19.83K | Conversion of Exercise of derivative security |
REED JOHN C |
Officer | 24.91K | Conversion of Exercise of derivative security |
SCHMID TIMOTHY |
Officer | 26.25K | Sale |
SWANSON JAMES D |
Chief Technology Officer | 25.70K | Sale |
TAUBERT JENNIFER L |
Officer | 194.45K | Sale |
WENGEL KATHRYN E |
Chief Technology Officer | 114.66K | Sale |
WOLK JOSEPH J |
Chief Financial Officer | 85.01K | Sale |
Fundamentals
Market cap$613.99B
Enterprise value$642.27B
Revenue (TTM)$97.93B
Gross profit$66.73B
EBITDA$34.87B
Net income$21.04B
EPS (TTM)$8.63
Free cash flow$16.89B
Total cash$20.76B
Total debt$49.04B
Book value / share$35.28
Shares outstanding2.41B
Float2.41B
Short % of float0.98%
Dividend yield2.12%
Beta (5Y)0.21
Valuation & profitability ratios
Trailing P/E29.52
Forward P/E21.05
PEG ratio2.65
Price / sales—
Price / book7.22
EV / revenue6.56
EV / EBITDA18.42
Gross margin68.14%
Operating margin29.19%
Profit margin21.48%
Return on equity25.74%
Return on assets8.60%
Debt / equity57.71
Current ratio1.09
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $94.19B | $88.82B | $85.16B | $79.99B | +6.0% |
| Operating revenue | $94.19B | $88.82B | $85.16B | $79.99B | +6.0% |
| Cost of revenue | $30.26B | $27.47B | $26.55B | $24.60B | +10.1% |
| Gross profit | $63.94B | $61.35B | $58.61B | $55.39B | +4.2% |
| Research & development | $14.66B | $17.23B | $15.09B | $14.13B | -14.9% |
| Selling, general & admin | $23.68B | $22.87B | $21.51B | $20.25B | +3.5% |
| Total operating expense | $38.34B | $40.10B | $36.60B | $34.38B | -4.4% |
| Operating income | $25.60B | $21.25B | $22.01B | $21.01B | +20.5% |
| Net interest income | $85.00M | $577.00M | $489.00M | $214.00M | -85.3% |
| Pre-tax income | $32.58B | $16.69B | $15.06B | $19.36B | +95.2% |
| Tax provision | $5.78B | $2.62B | $1.74B | $2.99B | +120.4% |
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | +90.6% |
| Net income to common | $26.80B | $14.07B | $35.15B | $17.94B | +90.6% |
| Basic EPS | 11.13 | 5.84 | 14.60 | 6.86 | +90.5% |
| Diluted EPS | 11.03 | 5.79 | 13.72 | 6.73 | +90.5% |
| EBIT | $33.55B | $17.44B | $15.83B | $19.64B | +92.4% |
| EBITDA | $41.05B | $24.78B | $23.32B | $26.61B | +65.7% |
| Basic shares | 2.41B | 2.41B | 2.41B | 2.61B | +0.0% |
| Diluted shares | 2.43B | 2.43B | 2.56B | 2.66B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.71B | $24.11B | $21.86B | $12.89B | — | -18.2% |
| Cash & short-term investments | $20.10B | $24.52B | $22.93B | $22.28B | — | -18.0% |
| Accounts receivable | $17.18B | $14.84B | $14.87B | $14.04B | — | +15.7% |
| Inventory | $14.19B | $12.44B | $11.18B | $10.27B | — | +14.0% |
| Total current assets | $55.62B | $55.89B | $53.49B | $55.29B | — | -0.5% |
| Property, plant & equipment | $23.17B | $20.52B | $19.90B | $17.98B | — | +12.9% |
| Goodwill & intangibles | $99.17B | $81.82B | $70.73B | $74.54B | — | +21.2% |
| Total assets | $199.21B | $180.10B | $167.56B | $187.38B | — | +10.6% |
| Total current liabilities | $54.13B | $50.32B | $46.28B | $55.80B | — | +7.6% |
| Current debt | $8.49B | $5.98B | $3.45B | $12.76B | — | +42.0% |
| Long-term debt | $39.44B | $30.65B | $25.88B | $26.89B | — | +28.7% |
| Total debt | $47.93B | $36.63B | $29.33B | $39.64B | — | +30.8% |
| Total liabilities | $117.67B | $108.61B | $98.78B | $110.57B | — | +8.3% |
| Retained earnings | — | — | $153.84B | $128.34B | $123.06B | — |
| Shareholder equity | $81.54B | $71.49B | $68.77B | $76.80B | — | +14.1% |
| Working capital | $1.50B | $5.57B | $7.21B | -$508.00M | — | -73.1% |
| Net tangible assets | -$17.63B | -$10.33B | -$1.96B | $2.27B | — | -70.7% |
| Shares issued | 3.12B | 3.12B | 3.12B | 3.12B | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | +90.6% |
| Depreciation & amortisation | $7.50B | $7.34B | $7.49B | $6.97B | +2.2% |
| Stock-based compensation | $1.35B | $1.18B | $1.16B | $1.14B | +15.1% |
| Change in working capital | -$12.72B | $1.84B | $2.51B | -$4.01B | -792.3% |
| Operating cash flow | $24.53B | $24.27B | $22.79B | $21.19B | +1.1% |
| Capital expenditure | -$5.22B | -$6.21B | -$5.01B | -$4.01B | +15.9% |
| Investing cash flow | -$23.59B | -$18.60B | $878.00M | -$12.37B | -26.8% |
| Share buybacks | -$5.95B | -$2.43B | -$5.05B | -$6.04B | -144.8% |
| Dividends paid | -$12.38B | -$11.82B | -$11.77B | -$11.68B | -4.7% |
| Financing cash flow | -$5.54B | -$3.13B | -$15.82B | -$8.87B | -76.9% |
| Free cash flow | $19.31B | $18.06B | $17.78B | $17.18B | +6.9% |
| End cash position | $19.71B | $24.11B | $21.86B | $14.13B | -18.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $25.31B | $24.06B | $24.56B | $23.99B | $23.74B | +5.2% |
| Operating revenue | $25.31B | $24.06B | $24.56B | $23.99B | $23.74B | +5.2% |
| Cost of revenue | $8.05B | $8.11B | $7.97B | $7.30B | $7.63B | -0.7% |
| Gross profit | $17.26B | $15.96B | $16.60B | $16.69B | $16.11B | +8.2% |
| Research & development | $3.65B | $3.53B | $4.25B | $3.67B | $3.52B | +3.6% |
| Selling, general & admin | $6.43B | $6.03B | $6.75B | $5.92B | $5.89B | +6.6% |
| Total operating expense | $10.09B | $9.56B | $11.01B | $9.59B | $9.40B | +5.5% |
| Operating income | $7.17B | $6.39B | $5.59B | $7.10B | $6.71B | +12.2% |
| Net interest income | -$62.00M | -$43.00M | $23.00M | -$18.00M | -$48.00M | -44.2% |
| Pre-tax income | $6.75B | $5.99B | $4.97B | $7.49B | $6.49B | +12.6% |
| Tax provision | $1.21B | $755.00M | -$150.00M | $2.34B | $954.00M | +60.7% |
| Net income | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | +5.7% |
| Net income to common | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | +5.7% |
| Basic EPS | 2.30 | 2.17 | 2.12 | 2.14 | 2.30 | +5.9% |
| Diluted EPS | 2.27 | 2.14 | 2.10 | 2.12 | 2.29 | +6.1% |
| EBIT | $7.03B | $6.26B | $5.18B | $7.74B | $6.80B | +12.2% |
| EBITDA | $8.99B | $8.27B | $7.19B | $9.52B | $8.74B | +8.7% |
| Basic shares | 2.41B | 2.41B | 2.41B | 2.41B | 2.41B | -0.0% |
| Diluted shares | 2.44B | 2.45B | 2.44B | 2.43B | 2.42B | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.42B | $21.69B | $19.71B | $18.23B | $18.58B | -5.8% |
| Cash & short-term investments | $20.76B | $22.05B | $20.10B | $18.56B | $18.88B | -5.9% |
| Accounts receivable | $19.05B | $17.72B | $17.18B | $17.61B | $17.85B | +7.5% |
| Inventory | $15.14B | $14.58B | $14.19B | $14.15B | $13.41B | +3.8% |
| Total current assets | $59.77B | $59.17B | $55.62B | $54.61B | $54.50B | +1.0% |
| Property, plant & equipment | $23.58B | $23.27B | $23.17B | $22.34B | $21.95B | +1.3% |
| Goodwill & intangibles | $96.71B | $97.62B | $99.17B | $96.78B | $97.95B | -0.9% |
| Total assets | $201.06B | $200.89B | $199.21B | $192.82B | $193.39B | +0.1% |
| Total current liabilities | $54.90B | $57.72B | $54.13B | $50.87B | $54.18B | -4.9% |
| Current debt | $11.69B | $17.46B | $8.49B | $6.39B | $11.53B | -33.0% |
| Long-term debt | $37.34B | $37.53B | $39.44B | $39.41B | $39.23B | -0.5% |
| Total debt | $49.04B | $54.99B | $47.93B | $45.80B | $50.76B | -10.8% |
| Total liabilities | $116.09B | $119.71B | $117.67B | $113.54B | $114.92B | -3.0% |
| Shareholder equity | $84.97B | $81.19B | $81.54B | $79.28B | $78.47B | +4.7% |
| Working capital | $4.88B | $1.46B | $1.50B | $3.74B | $318.00M | +234.9% |
| Net tangible assets | -$11.74B | -$16.43B | -$17.63B | -$17.51B | -$19.48B | +28.6% |
| Shares issued | 2.41B | 3.12B | 3.12B | 3.12B | 3.12B | -22.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | +5.7% |
| Depreciation & amortisation | $1.96B | $2.00B | $2.01B | $1.78B | $1.94B | -2.2% |
| Stock-based compensation | $458.00M | $300.00M | $309.00M | $347.00M | $410.00M | +52.7% |
| Change in working capital | $1.02B | -$5.23B | $3.60B | -$369.00M | -$4.92B | +119.5% |
| Operating cash flow | $8.62B | $2.51B | $7.31B | $9.17B | $3.88B | +242.7% |
| Capital expenditure | -$1.32B | -$1.05B | -$1.84B | -$1.17B | -$1.40B | -25.9% |
| Investing cash flow | -$1.11B | -$1.04B | -$4.49B | -$542.00M | -$18.26B | -6.7% |
| Share buybacks | -$221.00M | -$4.03B | -$1.92B | -$1.90B | $0 | +94.5% |
| Dividends paid | -$3.23B | -$3.13B | -$3.13B | -$3.13B | -$3.13B | -3.1% |
| Financing cash flow | -$8.78B | $530.00M | -$1.37B | -$8.93B | -$5.67B | -1,756.0% |
| Free cash flow | $7.29B | $1.47B | $5.47B | $8.00B | $2.48B | +398.0% |
| End cash position | $20.42B | $21.69B | $19.71B | $18.23B | $18.58B | -5.8% |
Options analytics
Put / call volume
0.67
Call-heavy session
Put / call open interest
0.80
Positioning, not flow
Max pain
260.00
+2.0% from spot
ATM implied vol
28.0%
Nearest strike to spot
Skew (10% OTM)
+5.0%
Puts bid over calls
Call volume
1.81K
Contracts, this expiry
Put volume
1.21K
Contracts, this expiry
Heaviest call OI
275.00
854 contracts
Heaviest put OI
260.00
1.05K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.85 | 2.90 | +1.6% |
| Mar 2026 | 2.68 | 2.70 | +0.9% |
| Dec 2025 | 2.46 | 2.46 | -0.1% |
| Sep 2025 | 2.76 | 2.80 | +1.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.50 | 10 | $25.35B | +5.7% |
| Next quarter | 2.94 | 9 | $26.53B | +8.0% |
| Current year | 11.07 | 11 | $101.38B | +7.6% |
| Next year | 12.13 | 10 | $108.63B | +7.1% |
Analyst targets & ownership
Mean target$279.64
High target$320.00
Low target$190.00
Implied upside9.66%
Analyst count22
ConsensusBUY
Strong buy / Buy5 / 11
Hold6
Sell / Strong sell1 / 0
Held by insiders0.05%
Held by institutions76.72%
Institutions holding5.79K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
263.77
-3.33% from price
SMA 20
265.82
-4.15% from price
SMA 50
265.57
-4.06% from price
SMA 100
254.10
+0.35% from price
SMA 200
242.15
+5.22% from price
EMA 12
262.23
-2.76% from price
EMA 26
264.79
-3.70% from price
EMA 50
263.20
-3.11% from price
RSI (14)
33.3
Neutral
MACD (12,26,9)
-2.56
Hist -2.09
ATR (14)
4.81
1.89% of price
Realised vol 30D
16.5%
Annualised
Bollinger upper
276.85
20, 2σ
Bollinger lower
254.79
20, 2σ
50 / 200 cross
Golden
265.57 vs 242.15
Trend bias
Above 200
+5.22%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.18
Less volatile than market
Correlation to SPY
-0.12
Largely independent
Realised vol 30D
16.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-11.0%
Peak to trough
Max drawdown 5Y
-23.6%
Peak to trough
ATR 14
4.81
1.89% of price
Beta (reported)
0.21
5Y monthly, from filing
Short interest
Shares short
21.19M
Prior 21.59M
Change vs prior
-1.9%
Shorts covering
% of float
0.98%
Normal
% of shares out
0.88%
Against total outstanding
Days to cover
3.4
Liquid
Float
2.41B
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Oct 5, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Sep 29, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Sep 10, 26 | HSBC | MAINTAINED | Buy | Buy |
| Sep 2, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 17, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 16, 26 | Raymond James | MAINTAINED | Outperform | Outperform |
| Jul 16, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 16, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 16, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$5.36 / yr
Forward yield2.12%
5-year avg yield2.68%
Payout ratio60.72%
Ex-dividend dateAug 25, 2026
Next pay dateSep 8, 2026
Last split2:1
Split dateJun 13, 2001
SEC filings
Annual Report of Proxy Voting Record of Registered Management Investment Companies filed on Form N-PX
N-PX · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-28
Periodic Financial Reports
10-Q · 2026-07-23
Corporate Changes & Voting Matters
8-K · 2026-07-15
Annual report of employee stock purchase
11-K · 2026-06-25
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-27
Headlines
Two of America’s Biggest Money Voices Give Opposite Advice on Dividend Stocks
24/7 Wall St. · 7h ago
Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Share Its Reliability
24/7 Wall St. · 9h ago
Johnson & Johnson's Innovative Medicines Momentum Offsets MedTech Headwinds, RBC Capital Markets Says
MT Newswires · 10h ago
PFE vs. JNJ: Which Stock Is the Better Value Option?
Zacks · 10h ago
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
Zacks · 10h ago
What Could Lift ISRG Stock?
Trefis · 11h ago
Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?
Zacks · 12h ago
Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief
The Wall Street Journal · 13h ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.